J. Stern & Co. LLP, a registered investment adviser, initiated a new position in DexCom, Inc. (NASDAQ:DXCM) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 1,601,973 shares of the Healthcare company, valued at approximately $1.6B as of the filing date.
DexCom, Inc.'s stock currently trades at $72.86 with a market capitalization of $27.0B.
